🇺🇸 FDA

Drug profile · INN

bortezomib

BORTEZOMIB ACCORD

approved L01XG01
US status
approved
Patents linked
4
News articles
0

Quick answer

bortezomib (BORTEZOMIB ACCORD) is an FDA-listed pharmaceutical active ingredient. Associated with MAIA Biotechnology. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN bortezomib
Brand BORTEZOMIB ACCORD
Route INJECTION
Formulation INJECTABLE
ATC code L01XG01
Originator MAIA Biotechnology

Related patents

Search patents →

  1. US 12005069

    Bortezomib compositions

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11752164

    Bortezomib compositions

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11679119

    Bortezomib compositions

    Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11672813

    Bortezomib compositions

    Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is bortezomib?

bortezomib (BORTEZOMIB ACCORD) is an FDA-listed pharmaceutical active ingredient. Associated with MAIA Biotechnology. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for bortezomib?

BORTEZOMIB ACCORD is a marketed brand name for bortezomib. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of bortezomib?

bortezomib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.